Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus Erythematosus

NCT01240694 is registered in ClinicalTrials.gov with Cephalon, Inc. as lead sponsor.

NCT NCT01240694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01240694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Patients With Systemic Lupus Erythematosus
Lead sponsor
Cephalon, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
December 9, 2010
Completion date
June 14, 2012
Enrollment
136 (actual)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus